Tool
Lab tracker
Enter your baseline, 3-month and latest results. See where each one sits and what changed, then take the printout to your doctor.
Compiled by Jayakanthan, Richmond, Virginia
Last reviewed against sources: October 25, 2026
This site is curated for my own family members. It is not a recommendation or a diet plan for anyone else. Do not change your diet, start fasting, or change any medicine without your own doctor's advice. We are not responsible for any consequences of following this information without proper medical supervision.
Lab tracker · Fasting planner · Food lookup
Your numbers are saved only in this browser on this device. Nothing is sent anywhere. Ranges come from the guidelines cited on Before you start[1,2,3,4]; a coloured dot is a prompt for a conversation with your doctor, not a diagnosis.
| Test | Baseline | ~3 months | Latest | Where it sits |
|---|
within the common cut-off borderline outside the range: discuss with your doctor no result or no standard range
1Notes on the ranges#
- HbA1c and fasting glucose: ADA 2026 cut points for prediabetes and diabetes[1].
- Lp(a): under 75 nmol/L (about 30 mg/dL) low, 125 nmol/L (about 50 mg/dL) or more high[2]. Test once in your life. If your report is in mg/dL, choose that unit above; the tracker converts approximately (the two units do not convert exactly).
- Units: glucose in mmol/L is converted at 18 mg/dL per mmol/L, and B12 in pmol/L at 1 pg/mL = 0.738 pmol/L. The table rows show the US unit.
- Green dots mean "within the common cut-off", not "your target". Your doctor may set tighter targets, especially for LDL if you have diabetes or heart disease.
- ALT: "truly healthy" upper limits of 33 U/L for men and 25 for women, lower than many lab report ranges[3].
- eGFR and urine ACR: kidney staging[4].
- B12: the diabetes prevention trial used 203 pg/mL or less as low[5]; many labs treat 200 to 300 as borderline.
- Triglycerides, HDL, LDL, uric acid, TSH, blood pressure: commonly used US clinical thresholds; your doctor may set different targets based on your overall risk.
- ApoB and non-HDL: no single target applies to everyone; watch the change from your baseline.
Sources on this page
Every source below was checked against its PubMed, DOI or publisher page. Grades and how we use them: evidence grades.
- American Diabetes Association Professional Practice Committee for Diabetes (2026). 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes-2026.. Diabetes Care 49(Supplement_1):S27-S49. PMID 41358893 · doi:10.2337/dc26-S002 - ADA Standards of Care 2026, Section 2
- Koschinsky ML, Bajaj A, Boffa MB, et al. (2024). A focused update to the 2019 NLA scientific statement on use of lipoprotein(a) in clinical practice.. J Clin Lipidol 18(3):e308-e319. PMID 38565461 · doi:10.1016/j.jacl.2024.03.001 - National Lipid Association statement
- Kwo PY, Cohen SM, Lim JK (2017). ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries.. Am J Gastroenterol 112(1):18-35. PMID 27995906 · doi:10.1038/ajg.2016.517 - ACG clinical guideline
- Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group (2024). KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease.. Kidney Int 105(4S):S117-S314. PMID 38490803 · doi:10.1016/j.kint.2023.10.018 - KDIGO 2024 CKD guideline
- Aroda VR, Edelstein SL, Goldberg RB, et al. (2016). Long-term Metformin Use and Vitamin B12 Deficiency in the Diabetes Prevention Program Outcomes Study.. J Clin Endocrinol Metab 101(4):1754-1761. PMID 26900641 · doi:10.1210/jc.2015-3754 - DPP Outcomes Study, metformin and B12